Clinical Trial Update: A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) [Phase 2]

View source ↗

Summary

Phase 2 trial update for caspofungin in Japanese children and adolescents with Candida or Aspergillus infections completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Candidiasis Esophageal
• Candidiasis Invasive

Drugs mentioned

• Caspofungin (caspofungin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Candidiasis, Esophageal, Candidiasis, Invasive | Phase 2 | Status: COMPLETED | Results posted: 2014-04-23